Recent us case of variant Creutzfeldt-Jakob disease—global implications

Emerging Infectious Diseases

Volumn 21, Issue 5, 2015, Pages 750-759

  Maheshwari, Atul ^a,b   Fischer, Michael ^c   Gambetti, Pierluigi ^d   Parker, Alicia ^a,b   Ram, Aarthi ^a,b   Soto, Claudio ^e   Concha Marambio, Luis ^e,f   Cohen, Yvonne ^d   Belay, Ermias D ^g   Maddox, Ryan A ^g   Mead, Simon ^h   Goodman, Clay ^a   Kass, Joseph S ^a,b   Schonberger, Lawrence B ^g   Hussein, Haitham M ⁱ  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARRIS COUNTY HOSPITAL DISTRICT   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSIDAD DE LOS ANDES   (Chile)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOCHEMISTRY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EVIDENCE BASED PRACTICE; HISTOPATHOLOGY; HUMAN; INFECTION CONTROL; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PUBLIC HEALTH; RISK FACTOR; UNITED STATES; VARIANT CREUTZFELDT JAKOB DISEASE; ADULT; ANIMAL; BIOPSY; BOVINE; BRAIN; CASE REPORT; CREUTZFELDT-JAKOB SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; HEALTH; HEALTH SURVEY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; TRANSMISSION; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ANIMALS; BIOPSY; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; GLOBAL HEALTH; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; POPULATION SURVEILLANCE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84928016052     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2105.142017     Document Type: Article

References (37)

1. Prusiner SB. Cell biology. A unifying role for prions in neurodegenerative diseases. Science. 2012;336:1511–3. http://dx.doi.org/10.1126/science.1222951
2. Barria MA, Ironside JW, Head MW. Exploring the zoonotic potential of animal prion diseases: in vivo and in vitro approaches. Prion. 2014;8:85–91. http://dx.doi.org/10.4161/pri.28124
3. Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, et al. Variant CJD: 18 years of research and surveillance. Prion. 2014;8:286–95. http://dx.doi.org/10.4161/pri.29237
4. Sanchez-Juan P, Cousens SN, Will RG, van Duijn CM. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg Infect Dis. 2007;13:1166–9. http://dx.doi.org/10.3201/eid1308.070178
5. Food and Drug Administration. 2011 Meeting materials, Transmissible Spongiform Encephalopathies Advisory Committee [cited 2014 Oct 1]. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/TransmissibleSpongiformEncephalopathiesAdvisoryCommittee/ucm261283.htm
6. Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park K-W, et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med. 2014;371:530–9. http://dx.doi.org/10.1056/NEJMoa1404401
7. Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry. 2011;82:646–51. http://dx.doi.org/10.1136/jnnp.2010.232264
8. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–5. http://dx.doi.org/10.1016/S0140-6736(96)91412-9
9. Barash J. Identification of Creutzfeldt-Jakob disease variants. [author reply 1045–6]. Arch Neurol. 2009;66:1045. http://dx.doi.org/10.1001/archneurol.2009.143
10. Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol. 2009;66:208–15.
11. Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67:761–70.
12. World Health Organization Department of Communicable Disease Surveillance and Response. WHO recommended surveillance standards, 1999 [cited 2015 Mar 8]. http://www.who.int/csr/resources/publications/surveillance/whocdscsrisr992.pdf
13. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659–68.
14. Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol. 2003;24:1560–9.
15. Ugnon-Café S, Dorey A, Bilheude JM, Streichenberger N, Viennet G, Meyronet D, et al. Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease. J Virol Methods. 2011;175:216–23. http://dx.doi.org/10.1016/j.jviromet.2011.05.016
16. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 1999;353:183–9. http://dx.doi.org/10.1016/S0140-6736(98)12075-5
17. Lukic A, Mead S, Rudge P, Collinge J. Comment on validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. [author reply 212–3]. Ann Neurol. 2011;69:212. http://dx.doi.org/10.1002/ana.22273
18. Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001;70:744–8. http://dx.doi.org/10.1136/jnnp.70.6.744
19. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet. 1997;350:903–7. http://dx.doi.org/10.1016/S0140-6736(97)07472-2
20. Beck JA, Poulter M, Campbell TA, Adamson G, Uphill JB, Guerreiro R, et al. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat. 2010;31:E1551–63. http://dx.doi.org/10.1002/humu.21281
21. Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, Korteweg J, et al. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol. 2014;71:421–8. http://dx.doi.org/10.1001/jamaneurol.2013.6001
22. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet. 2011;377:487–93. http://dx.doi.org/10.1016/S0140-6736(10)62308-2
23. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–33. http://dx.doi.org/10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
24. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213–39. http://dx.doi.org/10.1093/bmb/66.1.213
25. Gambetti P, Cali I, Notari S, Kong Q, Zou W-Q, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol. 2011;121:79–90. http://dx.doi.org/10.1007/s00401-010-0761-3
26. Sikorska B, Knight R, Ironside JW, Liberski PP. Creutzfeldt-Jakob disease. Adv Exp Med Biol. 2012;724:76–90. http://dx.doi.org/10.1007/978-1-4614-0653-2_6
27. Mihara M, Sugase S, Konaka K, Sugai F, Sato T, Yamamoto Y, et al. The “pulvinar sign” in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin’s lymphoma. J Neurol Neurosurg Psychiatry. 2005;76:882–4. http://dx.doi.org/10.1136/jnnp.2004.049783
28. Ryan AM, Ryan J, Wan-Ahmed M, Hardiman O, Farrell MA, McNamara B, et al. Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. BMJ Case Rep. 2009; 2009:pii: bcr08.2008.0650.
29. Schmidt C, Plickert S, Summers D, Zerr I. Pulvinar sign in Wernicke’s encephalopathy. CNS Spectr. 2010;15:215–8.
30. US Census Bureau. The foreign-born population in the United States [cited 2014 Aug 27]. https://www.census.gov/newsroom/pdf/cspan_fb_slides.pdf
31. Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS ONE. 2010;5:e15626. http://dx.doi.org/10.1371/journal.pone.0015626
32. Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect Dis. 2003;3:4. http://dx.doi.org/10.1186/1471-2334-3-4
33. Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science. 2001;294:1726–8. http://dx.doi.org/10.1126/science.1066838
34. Brown P, Brandel J-P, Sato T, Nakamura Y, MacKenzie J, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18:901–7. http://dx.doi.org/10.3201/eid1806.120116
35. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, et al. Kuru in the 21st century—an acquired human prion disease with very long incubation periods. Lancet. 2006;367:2068–74. http://dx.doi.org/10.1016/S0140-6736(06)68930-7
36. Boëlle P-Y, Cesbron J-Y, Valleron A-J. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis. 2004;4:26. http://dx.doi.org/10.1186/1471-2334-4-26
37. Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675. http://dx.doi.org/10.1136/bmj.f5675